Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Helena Meyer-Berg

BSc, MSc

DPhil Student

My DPhil project focuses on investigating  gene therapy for surfactant protein B deficiency using AAV vectors. Surfactant protein B deficiency is an autosomal recessive genetic disorder which is fatal during the first months of life.  Conventional therapy has been shown to be ineffective in those affected. Surfactant protein B plays a major role in surfactant homeostasis. Surfactant is a thin film that covers the gas exchange surface in the lung and prevents the lung from collapsing.

Before joining the Gene Medicine group in October 2017, I completed my Bachelor's and Master's degree in Biochemistry at Ludwig-Maximilians-Univerity Munich. During my Master thesis, I investigated immunotherapy to target HBV-associated hepatocellular carcinoma.